Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice.

× No keyword cloud information.

50 in total

1. Nucleotide sequence of rat hsp60 (chaperonin, GroEL homolog) cDNA.

Authors: T J Venner; R S Gupta
Journal: Nucleic Acids Res Date: 1990-09-11 Impact factor: 16.971

Review 2. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

Authors: L Castaño; G S Eisenbarth
Journal: Annu Rev Immunol Date: 1990 Impact factor: 28.527

3. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

Authors: D C Wraith; D E Smilek; D J Mitchell; L Steinman; H O McDevitt
Journal: Cell Date: 1989-10-20 Impact factor: 41.582

Review 4. Autoimmunity, microbial immunity and the immunological homunculus.

Authors: I R Cohen; D B Young
Journal: Immunol Today Date: 1991-04

5. Efficient mapping and characterization of a T cell epitope by the simultaneous synthesis of multiple peptides.

Authors: R Van der Zee; W Van Eden; R H Meloen; A Noordzij; J D Van Embden
Journal: Eur J Immunol Date: 1989-01 Impact factor: 5.532

6. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein.

Authors: A Ben-Nun; H Wekerle; I R Cohen
Journal: Nature Date: 1981-07-02 Impact factor: 49.962

Review 7. Immunological tolerance.

Authors: J G Howard; N A Mitchison
Journal: Prog Allergy Date: 1975

8. Adjuvant polyarthritis. VIII. Differences in immunopathogenesis between type II collagen arthritis and adjuvant arthritis.

Authors: Y H Chang; Y Iizuka
Journal: Agents Actions Date: 1984-12

9. Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II.

Authors: J Holoshitz; A Matitiau; I R Cohen
Journal: J Clin Invest Date: 1984-01 Impact factor: 14.808

10. Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein.

Authors: M F van den Broek; E J Hogervorst; M C Van Bruggen; W Van Eden; R van der Zee; W B van den Berg
Journal: J Exp Med Date: 1989-08-01 Impact factor: 14.307

6 in total

Review 1. Heat shock proteins. Introduction.

Authors: U Feige; J Mollenhauer
Journal: Experientia Date: 1992-07-15

The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice.

1. Nucleotide sequence of rat hsp60 (chaperonin, GroEL homolog) cDNA.

Review 2. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

3. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

Review 4. Autoimmunity, microbial immunity and the immunological homunculus.

5. Efficient mapping and characterization of a T cell epitope by the simultaneous synthesis of multiple peptides.

6. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein.

Review 7. Immunological tolerance.

8. Adjuvant polyarthritis. VIII. Differences in immunopathogenesis between type II collagen arthritis and adjuvant arthritis.

9. Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II.

10. Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein.

Review 1. Heat shock proteins. Introduction.

Review 2. Hsp70--a multi-gene, multi-structure, multi-function family with potential clinical applications.

Review 3. Heat shock proteins in autoimmune disease. From causative antigen to specific therapy?

4. Presence of hsp65 in bacterial extracts (OM-89): a possible mediator of orally-induced tolerance?

Review 5. Hsp70: a carrier molecule with built-in adjuvanticity.

6. HSP60: issues and insights on its therapeutic use as an immunoregulatory agent.